{"id":"W2112474467","doi":"10.1200/jco.2007.15.9319","title":"Phase I, Pharmacokinetic and Pharmacodynamic Study of the Anti–Insulinlike Growth Factor Type 1 Receptor Monoclonal Antibody CP-751,871 in Patients With Multiple Myeloma","year":2008,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"American Society of Clinical Oncology; Pfizer","keywords":"Medicine; Pharmacokinetics; Tolerability; Pharmacodynamics; Dexamethasone; Internal medicine; Pharmacology; Endocrinology; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001122648,0.00143177,0.001839925,0.0003723878,0.0004557571,0.0009147518,0.0006983834,0.0007147033,0.001301371],"category_scores_gemma":[0.0006055222,0.0006548713,0.0008485322,0.0004029536,0.0009476623,0.0006094202,0.0002745287,0.002919512,0.0005473533],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001541151,"about_ca_system_score_gemma":0.002187087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001633075,"about_ca_topic_score_gemma":0.003357727,"domain_scores_codex":[0.9995672,0.0001575189,0.00001895341,0.00007189086,0.00009177241,0.00009266418],"domain_scores_gemma":[0.9994969,0.00006736361,0.0001188086,0.0000484445,0.00003559817,0.0002328678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3613481,0.1165688,0.03820392,0.001336175,0.002651984,0.0007298696,0.000639066,0.007095065,0.2656727,0.0003771582,0.005778832,0.1995984],"study_design_scores_gemma":[0.1746409,0.6925923,0.09076314,0.00004935413,0.001288955,0.001225988,0.0001340694,0.003769085,0.03027425,0.0001584224,0.005022507,0.0000810525],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967405,0.001379631,0.0003811103,0.0001450149,0.00002891598,0.0005086369,0.0002492486,0.000051452,0.0005155111],"genre_scores_gemma":[0.9954952,0.0009881852,0.0008731843,0.000430986,0.00006471351,0.0004175759,0.0008548532,0.0000191102,0.0008562484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001839925,"threshold_uncertainty_score":0.01118189,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08983225290521596,"score_gpt":0.4622123649232952,"score_spread":0.3723801120180792,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}